Advanced search
Publication Cover
International Journal of Women's Health Volume 7, 2015 - Issue
Submit an article Journal homepage
90
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)

Johannes Bitzer1 Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, SwitzerlandCorrespondence[email protected]
,
Maria Jesusa Banal-Silao2 University of the Philippines College of Medicine, Manila, Philippines
,
Hans-Joachim Ahrendt3 Praxis für Frauenheilkunde, Klinische Forschung und Weiterbildung (Clinical Research and Further Education), Magdeburg, Germany
,
Jaime Restrepo4 Centro de Investigación Clínica, Clinica Medellin Poblado, Medellin, Colombia
,
Marion Hardtke5 Global Clinical Development Operations, Bayer Pharma AG, Berlin, Germany
,
Ulrike Wissinger-Graefenhahn6 Global Medical Affairs Women’s Healthcare, Bayer Pharma AG, Berlin, Germany
&
Dietmar Trummer7 Clinical Statistics Europe, Bayer Pharma AG, Berlin, Germany
 show all
Pages 501-509 | Published online: 18 May 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Iñaki Lete, Günther Häusler, Axelle Pintiaux, Christian Jamin, Rossella E. Nappi, Christian Fiala, Nathalie Chabbert-Buffet & Paloma Lobo. (2017) The inconvenience due to women’s monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe. The European Journal of Contraception & Reproductive Health Care 22:5, pages 354-359.
Read now
Rogério Bonassi Machado, Luciano Melo Pompei, Mariangela Badalotti, Rui Ferriani, Achilles M. Cruz, Eliana Nahas & Hugo Maia$suffix/text()$suffix/text(). (2017) Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial. The European Journal of Contraception & Reproductive Health Care 22:1, pages 11-16.
Read now
Iñaki Lete & Oihane Lapuente. (2016) Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review. Open Access Journal of Contraception 7, pages 117-125.
Read now

Articles from other publishers (5)

Valeria Calcaterra, Rossella Elena Nappi, Andrea Farolfi, Lara Tiranini, Virginia Rossi, Corrado Regalbuto & Gianvincenzo Zuccotti. (2022) Perimenstrual Asthma in Adolescents: A Shared Condition in Pediatric and Gynecological Endocrinology. Children 9:2, pages 233.
Crossref
Aysun TEKELİ TAŞKÖMÜR, Özlem ERTEN & Berna DİLBAZ. (2021) Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 µg ethinylestradiol/3 mg drospirenone (24/4) versus 30 µg ethinylestradiol/3 mg drospirenone (21/7). Journal of Surgery and Medicine 5:11, pages 1099-1103.
Crossref
Wan-Lin Zhang, Zhe Dong, Jun-Yan Zhang, Min-Zhi Lyu, Wei Zhang, Jian-Lei Huang & Xin Yang. (2021) Comparison of Risks of Thromboembolism of Drospirenone-Containing and Nondrospirenone -Containing Combined Oral Contraceptive Use: A Meta-Analysis. Reproductive and Developmental Medicine 5:3, pages 154-160.
Crossref
G. B. Dikke. (2019) Combined oral contraceptives with shortened hormone-free interval. Proven advantages of the therapy regime. Medical Council:13, pages 56-62.
Crossref
Alessandra Graziottin & Audrey Serafini. (2016) Perimenstrual asthma: from pathophysiology to treatment strategies. Multidisciplinary Respiratory Medicine 11:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.